RJ
Rienk Jeeninga
Director Clinical Virology Services at Cerba Research
View Rienk's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Clinical Virology Services
Jun 2016 - Present · 8 years and 6 months
Manager Culture And Serology
Jan 2015 - Jun 2016 · 1 years and 5 months
Post-Doctoral Reseacher
Dec 2000 - Dec 2014 · 14 years
Company Details
1001-5000 Employees
At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming research, and advancing health together. Uniquely, we combine the experience of specialty laboratories with the global reach of a central lab. We have a worldwide network of 1000 labs, hold data from over 85 million patients across five continents, and have the ability to sequence 1000-plus whole human genomes per week. This unparalleled approach to patient data gives you the opportunity to have one partner for all your test services, with consistent access and support across all clinical trial phases.
Year Founded
1984
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
Industriepark Zwijnaarde 3 Ghent, Flemish Region 9052, BE
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Rienk Jeeninga in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.